Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.
Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.3.2 was added and v3.3.1 removed, indicating a backend version update with no visible changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check24 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed. The page revision note was updated to Revision: v3.3.1 (replacing v3.2.0).SummaryDifference0.1%
- Check32 days agoChange DetectedDeleted the government funding status notice about potential delays and operating status updates from the page. The core study details, eligibility criteria, and contacts remain unchanged.SummaryDifference0.3%
- Check46 days agoChange DetectedThe Study Details page shows cosmetic/layout updates; however the core content such as eligibility criteria and outcome measures remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check74 days agoChange DetectedUpdate includes a critical operating status notice and an upgraded version to v3.2.0, indicating the page has refreshed with new guidance on government funding and operating status.SummaryDifference2%
- Check76 days agoChange DetectedUpdated revision/version from v3.0.2 to v3.1.0. No substantive content changes detected.SummaryDifference0.1%
Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.